Navigation Links
Verenium Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2012

greements,  its ability to achieve milestones under existing and future collaboration agreements, the ability of Verenium and its partners to commercialize its technologies and products (including by obtaining any required regulatory approvals) using Verenium's technologies, the timing for launching any commercial products and projects, the ability of Verenium and its collaborators to market and sell any products that it or they commercialize, the development or availability of competitive products or technologies, the future ability of Verenium to enter into and/or maintain collaboration and joint venture or partnership agreements and licenses on a timely basis or at all, and risks and other uncertainties more fully described in Verenium's filings with the Securities and Exchange Commission, including, but not limited to, Verenium's annual report on Form 10-K for the year ended December 31, 2011 and any updates contained in its subsequently filed quarterly reports on Form 10-Q .  These forward-looking statements speak only as of the date hereof, and Verenium expressly disclaims any intent or obligation to update these forward-looking statements.

Contacts:Sarah Carmody
Sr. Manager, Corporate Communications

 Verenium CorporationCondensed Consolidated Statements of Operations (unaudited, in thousands, except per share amounts) Three Months Ended December 31, Year EndedDecember 31, 


20122011As Restated*As Restated*Revenues:Product

55,995Contract manufacturing

1,500--5,547--Collaborative and license

1,0955788,2695,272Total revenue

13,98314,32157,17161,267Operating expenses:Cost of product and contract manufacturing revenue

8,1348,30732,09634,481Product and contract manufacturing gross prof

SOURCE Verenium Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Verenium Announces Preliminary Financial Results For Fiscal 2012
2. Verenium To Present At The 25Th Annual Roth Conference
3. Verenium Appoints Holger Liepmann To Its Board Of Directors
4. Verenium To Sponsor The Renewable Fuels Association 18th Annual National Ethanol Conference
5. Novus International And Verenium Announce Important Progress In The Development Of Novel Enzymes For Animal Health & Nutrition
6. Verenium Announces $22.5 Million, Five-Year Secured Financing
7. Verenium Corporation To Announce Third Quarter 2012 Financial Results
8. Verenium Reports Financial Results For The Second Quarter And Six Months Ended June 30, 2012
9. Verenium Corporation To Announce Second Quarter 2012 Financial Results
10. Verenium Announces EPA Authorization To Market Its Next-Generation Enzyme Breaker For Hydraulic Fracturing
11. Verenium Corporation And Alexandria Real Estate Equities, Inc. Celebrate The Grand Opening Of A New State-of-the-art Biotechnology Facility
Post Your Comments:
(Date:9/23/2014)... Cambridge Semantics, the leading provider of ... named in the recent ‘Hype Cycle for Life Sciences ... report details key insights pertaining to the benefits in ... analysts Michael Shanler and Stephen Davies, “The use of ... relationships with scientific stakeholders, and support collaboration and innovation ...
(Date:9/23/2014)... 23, 2014 Marktech Optoelectronics has introduced ... violet emitters in the 280 nm wavelength range. This ... which range from 280nm to 405nm. These new devices ... as well as curing. Mark Campito, Marktech’s CEO states ... interest to manufacturers is that we offer it in ...
(Date:9/23/2014)... 23, 2014 New spin-out ... Innovations, Cambridge Innovation Capital and Johnson & Johnson ... genomics company focused on harnessing the potential of ... testing and treatment, today announced it has raised ... Innovations and including Cambridge Innovation Capital and Johnson ...
(Date:9/22/2014)... 2014 Research and Markets ... the "Global Biotechnology Reagents Market 2014-2018" ... Biotechnology reagents are chemical compounds ... to detect and examine another substance to provide ... laboratories to prepare, collect, and examine specimens from ...
Breaking Biology Technology:Cambridge Semantics Identified in Gartner’s ‘Hype Cycle for Life Sciences 2014’ Report 2Marktech Introduces its New Line of Deep UV Emitters 2Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 2Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 3Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests 4Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 2Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 3
... announces that a new market research report is ... Biology: Emerging Global Markets ... INTRODUCTION ... goal for this study is to determine the specific ...
... necessity often taken for granted. However UNICEF estimates that ... access to safe drinking water. New research published in ... shows that an enteric virus-binding protein (EVBP), isolated from ... viruses often present in contaminated water. One of ...
... provider of comprehensive sample management solutions, including storage, cold ... the bioscience industry, is pleased to announce that Mike ... the Indianapolis Business Journal (IBJ). Reffeitt was recognized as ... $100 million or less in annual revenue. ...
Cached Biology Technology:Synthetic Biology: Emerging Global Markets 2Synthetic Biology: Emerging Global Markets 3Synthetic Biology: Emerging Global Markets 4Synthetic Biology: Emerging Global Markets 5Synthetic Biology: Emerging Global Markets 6Synthetic Biology: Emerging Global Markets 7Synthetic Biology: Emerging Global Markets 8Synthetic Biology: Emerging Global Markets 9Synthetic Biology: Emerging Global Markets 10Synthetic Biology: Emerging Global Markets 11BioStorage Technologies' Mike Reffeitt Named "CFO of the Year" by Indianapolis Business Journal 2
(Date:9/19/2014)... a newly discovered hadrosaur with a truly ... Rhinorex condrupus by paleontologists from North Carolina ... what is now Utah approximately 75 million years ... which translates roughly into "King Nose," was a ... hadrosaurs like Parasaurolophus and Edmontosaurus. Hadrosaurs are usually ...
(Date:9/19/2014)... Oklahoma biology professor will study the unique bioelectric signaling ... eventually benefit people,s health. The OU researcher is ... required to produce the signals used to map the ... at a rate of 500-600 discharges a second throughout ... electric fish are extreme, but necessary for survival. , ...
(Date:9/19/2014)... did not evolve for the sake of fairness per ... continued cooperation, so say Frans de Waal, PhD, and ... inequity aversion (IA), which is defined as a negative ... Science . , Their conclusion comes after ... address their hypothesis that it is the evolution of ...
Breaking Biology News(10 mins):New hadrosaur noses into spotlight 2Evolution of responses to (un)fairness 2Evolution of responses to (un)fairness 3
... evidence that a direct interaction between vitamin D and ... multiple sclerosis (MS). The research, published on 6 February ... that vitamin D deficiency during pregnancy and the early ... MS later in life. MS is the most ...
... (NYSE: CSC ) announced today that it ... and Support Services Unrestricted contract by the Department of ... (IDIQ) contract covers a broad range of services, solutions ... BTF business and program units. The contract has a ...
... Feb. 3 announces the availability of a commentary ... Controls, Inc. (OTC Bulletin Board: FOUR), Magal Security Systems Ltd. ... NSSC ), Pointer Telocation (Nasdaq: PNTR ... Systems Inc. (NYSE: CKP ).To view the ...
Cached Biology News:Genetic study shows direct link between vitamin D and MS susceptibility 'gene' 2Genetic study shows direct link between vitamin D and MS susceptibility 'gene' 3CSC Awarded Department of Defense Biometrics Contract Issues Commentary for Investors of Homeland Defense Companies FOUR, MAGS, NSSC, PNTR, BCO, and CKP 2
... The Mini-PROTEAN II multiscreen apparatus is used ... 7 cm) gels. The apparatus can screen up ... to cut the blot into strips. The apparatus ... templates that accommodate one or two 8 x ...
Fingerprinting II database sharing tools is an optional module for the Fingerprinting II Basic software package that enables peer-to-peer data exchange over the internet and provides external databas...
... Fingerprinting II ... is an optional ... principal component analysis, ... analysis and MANOVA, ...
Fingerprinting II comparative quantification and polymorphism analysis is an optional module that adds comparative quantification and polymorphism analysis functions to the Fingerprinting II Basic so...
Biology Products: